Analysis Date: 2025-12-29T01:08:34.833643 Trading Period: 2025-12-25 to 2026-01-08
Company: Hologic, Inc. Sector: Healthcare | Industry: Medical Instruments & Supplies Current Price: $74.50 Market Cap: $16,618,384,384 Beta: 0.70 Avg Volume: 3,410,561 P/E Ratio: 29.92 Website: https://www.hologic.com
Description: Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, an...
Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio
Rationale: Unfavorable conditions (composite: 7.4/100, risk: EXTREME, red flags: 0).
Key Strengths:
Passed Filters: ✗ No Notes: Failed one or more screening filters (volume, price, market cap, etc.)
Composite Score: 0.00/5.0 Percentile Rank: 0%
Factor Scores:
Setup Score: 1/8 Setup Notes: Chart patterns: Consolidation
Price Levels:
Momentum & Volume:
Chart Patterns:
Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 0 Earnings Risk: No
This report is generated by PM automated research system. Always perform your own due diligence before trading.